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section. The cumulative surgery rate after diagnosis of CD is 
reported to be 46%–62% at 5 years and 61%–75% at 10 years.2-4 
In addition, a greater number of strictureplasties is associated 
with a higher the risk of reoperation.5 To avoid the risk of short 
bowel syndrome, intestinal resection should be kept to a mini-
mum.6
Endoscopic balloon dilatation (EBD) has been shown to be 
an effective treatment that helps to avoid surgery,7-10 and the 
Japanese clinical practice guidelines for IBD recommend EBD 
when obstructive symptoms do not improve with drug thera-
py alone.11 Lian et al.12 reported that EBD could delay surgery 
for 6.45 years in a study of 176 EBD-treated and 131 surgically 
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Background/Aims: We retrospectively analyzed Crohn’s disease (CD) patients with small intestinal strictures who under-
went single-balloon enteroscopy (SBE) to ascertain whether prototype SBEs with a passive bending mechanism and high 
force transmission insertion tube had better insertability in the small intestine than a conventional SBE. Methods: Among 253 
CD patients who underwent SBE, we identified 94 CD patients who had undergone attempted endoscopic balloon dilatation 
(EBD) for small intestinal stenosis for inclusion in this study. We analyzed whether the type of scope used for their initial pro-
cedure affected the cumulative surgery-free rate. For the insertability analysis, patients who underwent SBE at least twice were 
divided into 3 groups according to the type of scope used: conventional SBE only, prototype SBE only, and both conventional 
and prototype SBEs. For each group, depth of insertion, procedure time, and number of EBDs were compared in the same pa-
tient at different time points. Results: The success rate of EBD was 88.3%. The 5- and 10-year cumulative surgery-free rate was 
75.7% and 72.8%, respectively. Cox regression analysis indicated that the factors contributing to surgery were long stricture 
( ≥ 2 cm), EBD failure, and elevated Crohn’s Disease Activity Index, but not the type of scope used for EBD. The prototype SBEs 
significantly improved the depth of insertion (P = 0.03, Wilcoxon’s signed-rank test). Conclusions: In CD patients with small 
intestinal stenosis, the prototype SBEs with a passive bending mechanism and high force transmission insertion tube did not 
improve long-term EBD outcome but did improve deep insertability. (Clinical Trial Registration No. UMIN000037102) (Intest 
Res 2020;18:229-237)
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ORIGINAL ARTICLE
INTRODUCTION
Crohn’s disease (CD) is a chronic inflammatory intestinal dis-
order that involves transmural inflammation of the GI tract 
and can potentially cause stricture and fistula formation.1 
Stricture in the small intestine is one of the most common in-
testinal complications and sometimes requires intestinal re-
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treated CD patients. Although it is reported that EBD failure, 
strictures with fistula, long stricture, and multiple stenoses are 
factors that contribute to intestinal resection in CD patients 
with stenosis in the small intestine,13-17 there are few reports 
about the long-term outcomes of EBD in CD patients with 
strictures in the small intestine.
We were given the opportunity to use prototype single-bal-
loon enteroscopes (SBEs) with a passive bending mechanism 
and high force transmission insertion tube. Colonoscopes 
with this mechanism and insertion tube have been reported 
to reduce the cecal intubation time and pain during the proce-
dure.18,19 In a prospective study of 60 patients, the use of a pro-
totype SBE with a passive bending mechanism and high force 
transmission insertion tube was found to shorten of terminal 
ileum intubation time compared with use of the SIF-Q260, a 
conventional SBE.19 However, in that study, the SBE was in-
serted only 20 cm from the ileocecal valve, and the results 
mainly reflect improvement of insertability in the colon. 
We conducted this retrospective study to test our hypothe-
sis that the prototype SBEs with a passive bending mecha-
nism and high force transmission insertion tube can be insert-
ed deeper than a conventional SBE in the small intestine in 
patients with stricturing CD who required EBD. We also ana-
lyzed whether the type of scope used affects the long-term 
outcomes of EBD. 
METHODS
1. Ethical Considerations
This retrospective study was approved by the Ethics Committee 
of Shiga University of Medical Science (approval No. R2019-
121) and informed consent was waived. The study is registered 
in the University Hospital Medical Network Clinical Trials Reg-
istry (UMIN000037102).
2. Patients
Among the 253 CD patients who underwent SBE at Shiga Uni-
versity of Medical Science from October 2005 to December 
2017, we identified 94 who had undergone attempted EBD for 
small intestinal stenosis for inclusion in this study (Fig. 1). The 
94 CD patients included 11 patients with unsuccessful EBD 
with failed dilation of stenosis. Disease phenotype and status 
was defined according to the Montreal classification.20
3. Scopes and Procedures
Four scopes were used in this study: the SIF-Q260 (Olympus, 
Tokyo, Japan), which is a conventional SBE that does not have 
a passive bending mechanism or high force transmission in-
sertion tube, and the SIF-Y0002, SIF-Y0007, and SIF-Y0013 
(Olympus), which are prototype SBEs that have a passive 
bending mechanism and high force transmission insertion 
tube. The specifications of the scopes are shown in Supple-
mentary Table 1. Briefly, SIF-Y0002 is a model based on SIF-
Q260 with addition of a passive bending mechanism and high 
force transmission insertion tube. SIF-Y0007 is a model based 
on SIF-Y0002 with addition of a magnifying mechanism. SIF-
Y0013 is a model designed for the 290 series light source and 
is equipped with a passive bending mechanism, a high force 
transmission insertion tube, and an instrumental channel of 
3.2 mm in diameter. 
The endoscope was selected by the endoscopist. If both 
conventional and prototype scopes could be used, the proto-
type SBE was often selected. However, if there were multiple 
endoscopic examinations on the same day, they were used al-
ternately by adjusting the cleaning time. All endoscopic pro-
cedures were performed by 3 experienced endoscopists (T.T., 
S.B., and K.T.).
EBD was performed using a through-the-scope balloon 
catheter (CRETM balloon dilatation catheter; Boston Scientific 
Fig. 1. Study participants. Among 253 CD patients who under-
went single-balloon enteroscopy (SBE), 94 underwent attempted 
endoscopic balloon dilatation (EBD) for small intestinal stenosis. 
The clinical characteristics of these 94 patients are shown in Table 
1. To compare the insertability, patients who underwent SBE at 
least twice during the observation period were extracted and di-
vided into 3 groups: conventional SBE only, prototype SBE only, 
and both conventional and prototype SBEs. Detailed information 
of these groups is shown in Table 3. 
Underwent SBE: 253 CD patients







No strictures found: 155 patients
EBD for upper GI or colonic strictures: 3 patients
Lost follow-up: 1 patient
Underwent enteroscopy only once: 26 patients
Details unknown: 5 patients
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Co., Natick, MA, USA). In principle, the dilatation balloon was 
inflated to at least 15 mm and maintained for 30 seconds to 2 
minutes. Carbon dioxide insufflation was performed during 
all procedures. EBD was performed under conscious sedation 
with midazolam or propofol.
We defined successful EBD as confirmation of dilatation of 
the stenosis under fluoroscopy. In patients with multiple small 
intestinal strictures, we defined successful EBD as confirmed 
dilatation of the stenosis responsible for the obstructive symp-
toms. Indications for EBD using SBE for small intestinal stric-
tures at our institution include the following: no fistula or ab-
scess in the stenosis and no untreated deep ulcer. At our insti-
tution, SBE is performed under fluoroscopic guidance to con-
firm the length and number of stenoses. If we find any asymp-
tomatic stenosis that prevents passage of the scope, we per-
form EBD on that stenosis. Patients were hospitalized until the 
day after EBD and were discharged after confirming there 
were no symptoms such as hemorrhage and abdominal pain 
on the day after EBD. Procedure-related complications were 
defined as intestinal perforation and active bleeding requiring 
surgery or blood transfusion. 
4. Long-term Outcome
The long-term outcome was determined as the cumulative 
surgery-free rate after initial EBD. Surgery was performed for 
strictures that were not resolved by medical or endoscopic 
therapy, or for intestinal perforation as a complication of EBD. 
We examined whether long-term outcome was influenced by 
clinical background, including stenotic status, blood biochem-
istry, and the scope initially used. The analysis of long-term 
outcome included patients who were observed for at least 3 
weeks after the initial EBD. 
5. Insertability and Scope Used
To investigate the usefulness of deep insertion of prototype 
SBEs with a passive bending mechanism and high force trans-
mission insertion tube, we selected cases in which 2 or more 
SBE procedures were performed during the follow-up period. 
We then divided these cases into 3 groups according to the 
scope used: (1) the conventional SBE only, (2) a prototype 
SBE only, and (3) both conventional and prototype SBEs. For 
comparison of deep insertability in the small intestine, the 2 
most recent procedures were compared in each group. When 
both the conventional and prototype SBEs were used, the 
most recent switching opportunity was compared. During all 
procedures, depth of small intestinal insertion was estimated 
using the method described by May et al.21 The procedure 
time was defined as starting insertion of the endoscope to fin-
ishing removal of the endoscope from the patient.
6. Statistical Analyses
Cumulative surgery-free rates were analyzed using the Ka-
plan-Meier method and log-rank test. In addition, factors con-
tributing to surgery were examined using Cox regression anal-
Table 1. Clinical Background of the Patients
Characteristic Value (n=94)
Sex (male/female) 77/17
Age at diagnosis (yr) 28.8±13.0
Age at first EBD (yr) 37.0±12.4
BMI (kg/m2) 21.3±3.3
Smoking (yes/no) 13/81
Age at diagnosis (A1/A2/A3) 8/72/14
Disease phenotype at first EBD (B1/B2/B3) 16/62/16
Disease location at first EBD (L1/L3) 52/42
Perianal lesion present (yes/no) 30/64
History of surgery (yes/no) 48/46
Success of EBD (yes/no) 83/11
Symptoms of obstruction before EBD (yes/no) 71/23
Serum albumin (g/dL) 3.8±0.5
Serum CRP (mg/dL) 0.6±1.0
CDAI at first EBD (point) 127.3±76.8
Concomitant treatments
  Thiopurine (yes/no) 29/65
  Anti-TNF-α antibody (yes/no) 43/51
Scope used for initial EBD 
  Conventional SBE 44
  Prototype SBE 50
Stricture site
  Single (%) 49
  Multiple (%) 45
    2 22
    3 11
    ≥4 12
  De novo type of strictures (yes/no) 77/17
  Stricture length (cm) 1.3±0.9
  Long stricture (≥2 cm, yes/no) 26/68
Values are presented as mean±SD. 
EBD, endoscopic balloon dilatation; A1, ≤16 years; A2, 17–40 years; A3, 
>40 years; B1, non-stricturing, non-penetrating; B2, stricturing; B3, 
penetrating; L1, ileal; L3, ileocolonic; SBE, single-balloon enteroscopy.
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ysis. All variables with P-values less than 0.15 in univariate 
analysis were entered into multivariate analysis. We also in-
cluded sex, age, and other factors previously described.13 Dif-
ferences in insertability were analyzed using Wilcoxon’s signed-
rank test. Statistical significance was defined as P < 0.05. Graph-
Pad Prism 8.0.0 (GraphPad, San Diego, CA, USA) and SPSS 
version 25.0 (IBM Corp., Armonk, NY, USA) were used for sta-
tistical analysis. 
RESULTS
A total of 94 CD patients with a mean follow-up period of 
1,886 days were included in this study. Baseline characteris-
tics at initial EBD are shown in Table 1. The mean number of 
EBDs performed per patient during the follow-up period was 
3.3, and the mean interval between the initial EBD and the 
second EBD was 508 days. Among 83 patients who under-
went successful EBD, 80 (96.4%) were initially dilated to more 
than 15 mm. Of the remaining 3 patients, 1 was initially dilated 
to 12 mm and 2 were initially dilated to 10 mm.
The EBD success rate was 88.3% (83/94). The 5- and 10-year 
cumulative surgery-free rate was 75.7% and 72.8%, respective-
ly (Fig. 2A). Table 2 shows the results of multivariate analysis 
of factors contributing to intestinal resection. Elevated CDAI, 
long stenosis ( ≥ 2 cm), and EBD failure were identified as fac-
tors contributing to intestinal resection. The results were also 
confirmed by Kaplan-Meier analysis (Fig. 2B-D). Factors such 
as prototype scope used for initial EBD, number of stenoses, 
and de novo stenosis were not associated with intestinal re-
section. In addition, the risk of surgery increased by 2.53 times 
when the length of stenosis increased by 1 cm in a successful 
EBD case (HR, 2.53; 95% CI, 1.580–4.069; P < 0.001).
During the follow-up period, 314 EBDs were performed in 
94 CD patients, and 4 patients (1.29%, 4/314) had intestinal 
perforation as a complication. There were no cases of bleeding 
requiring surgery or blood transfusion. 
The insertability and the scope used were compared be-
tween the groups shown in Table 3. We compared depth of in-
sertion, procedure time, and number of EBDs between 2 pro-
cedures in the same patient at different times (Fig. 3). Com-
Fig. 2. Cumulative surgery-free survival rate. Kaplan-Meier curves depicting cumulative surgery-free survival for all patients (A), and 
stratified by CDAI (B), stricture length (C), and endoscopic balloon dilatation (EBD) success (D). P-values for each curve were calculated 
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pared with conventional SBE, prototype SBE has significantly 
improved the depth of insertion (Fig. 3C). A representative 
case is shown in Fig. 4. Use of the prototype SBE improved the 
depth of insertion and increased the number of EBDs. 
DISCUSSION
The prototype SBEs with a passive bending mechanism and 
high transmission insertion tube did not affect long-term EBD 
outcome, but they did contribute to improving the depth of in-
sertion in the small intestine compared with the conventional 
SBE. This is the first study to show that prototype SBEs with 
this mechanism and insertion tube improve insertability in 
the strictured small intestine. 
The EBD success rate in this study was 88.3%, which is con-
sistent with the 62% to 100% success rate reported in a pooled 
analysis and meta-analyses.10,22,23 Our 5- and 10-year cumula-
tive surgery-free survival rate of 75.7% and 72.8%, respectively, 
was equivalent to the 3-year rate of 73% reported by Hirai et 
al.16 and are slightly better than the 1- and 3-year survival rates 
of 63.1% and 56.2%, respectively reported by Nishida et al.13 At 
our institution, patients who undergo EBD typically repeat 
procedures every 1 to 2 years for surveillance and evaluation 
regardless of the presence or absence of stenotic symptoms. 
In fact, 23 of the 94 patients (24.4%) had asymptomatic steno-
sis. The patients reported by Nishida et al.13 had stenotic symp-
toms, which may be the reason for the differences in results. 
In an EBD study involving strictures in both small and large 
intestine, it was reported that the HR for intestinal resection 
increased by 8% when the length of stenosis increased by 1 
cm.10 In our study, an increase in the length of stenosis in the 
small intestine by 1 cm increased intestinal resection by 2.53 
times. Our results suggest that increased length of stenosis in 
the small intestine may require more intestinal resection than 
increased length of stenosis in the colon. 
Multivariate analysis revealed that long stricture ( ≥ 2 cm), 
EBD failure, and elevated CDAI were factors contributing to in-
testinal resection of small intestinal stricture. Long stricture ( ≥ 2 
cm)17 and EBD failure16 have already been reported as factors 
contributing to intestinal resection. Although elevated CDAI 
Table 2. Factors Associated with Intestinal Resection for all CD Patients
Factor
Univariate analysis Multivariate analysis
HR (95% CI) P-value HR (95% CI) P-value
Male sex 0.830 (0.304–2.267) 0.715 0.560 (0.171–1.837) 0.339
Age at diagnosis 0.987 (0.947–1.028) 0.506 0.994 (0.949–1.042) 0.813
BMI 0.989 (0.867–1.128) 0.861 -
Smoking 0.867 (0.255–2.949) 0.820 -
Disease phenotype B2 0.840 (0.348–2.029) 0.698 -
Disease location L1 1.555 (0.644–3.753) 0.328 -
Perianal lesion present 1.615 (0.679–3.84) 0.279 -
History of surgery 1.807 (0.728–4.483) 0.202 3.598 (0.827–15.663) 0.088
Failure of EBD 18.927 (7.445–48.116) 0.001a 17.276 (3.546–84.159) <0.001a
Symptomatic bowel obstruction 2.118 (0.624–7.195) 0.230 -
Serum albumin (mg/dL) 0.693 (0.287–1.674) 0.415 -
Serum CRP (mg/dL) 1.287 (0.920–1.800) 0.142 1.008 (0.646–1.572) 0.974
CDAI 1.011 (1.005–1.016) 0.001a 1.007 (1.000–1.014) 0.039a
Use of thiopurines 0.535 (0.180–1.591) 0.261 -
Use of anti-TNF-α antibody 1.622 (0.683–3.851) 0.274 -
Prototype SBE 1.652 (0.677–4.027) 0.270 -
EBD for multiple strictures 0.554 (0.224–1.374) 0.203 0.374 (0.111–1.265) 0.114
De novo type of strictures 1.141 (0.383–3.407) 0.814 -
Long stricture (≥2 cm) 11.258 (4.109–30.845) 0.001a 4.737 (1.290–17.388) 0.019a
aSignificant factor. 
B2, stricturing; L1, ileal; EBD, endoscopic balloon dilatation; SBE, single-balloon enteroscopy.
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has been shown to be associated with intestinal resection in 
CD,24 these cohorts comprised 23% (20/86) colonic stenosis 
and 8% (7/86) upper GI stenosis. Therefore, the novel finding in 
this study is that the elevated CDAI could be related to intesti-
nal resection even in a cohort limited to the small intestine. 
Until now, there have been no reports on achieving deep in-
sertion in the small intestine using a prototype SBE with a pas-
sive bending mechanism and high force transmission inser-
tion tube. Although Hosoe et al.19 reported that the rate of in-
sertion to the terminal ileum 20 cm beyond the ileocecal valve 
within 10 minutes was improved from 86.2% to 96.8% by using 
a prototype SBE in a prospective study, the deep insertability 
in the small intestine has not been studied. Our findings indi-
cate that the depth of insertion can be significantly improved 
Table 3. Clinical Background of the Patients
Characteristic Conven tional SBE only (n=6)
Prototype SBE only 
(n=31)
Conventional and proto type SBE 
(n=26)
Sex (male/female) 4/2 27/4 19/7
Age at diagnosis (yr) 32.3±17.1 26.7±11.0 29.1±9.8
Age at first EBD (yr) 40.5±15.5 36.3±12.3 38.3±7.6
BMI (kg/m2) 21.3±3.8 20.8±3.1 21.3±3.1
Smoking (yes/no) 0/6 5/26 4/22
Conventional → prototype - - 23
Prototype → conventional - -   3
Age at diagnosis (A1/A2/A3) 1/4/1 3/25/3 1/22/3
Disease phenotype at first EBD (B1/B2/B3) 0/6/0 3/23/5 1/20/5
Disease location at first EBD (L1/L3) 3/3 19/12 17/9
Perianal lesion (yes/no) 0/6 14/17 5/21
History of surgery (yes/no) 3/3 16/15 15/11
Success of EBD (yes/no) 5/1 29/2 26/0
Symptoms of obstruction before EBD (yes/no) 6/0 20/11 24/2
Interval period (day) 353.8±188.9 625.7±440.1 847.8±765.9
Concomitant treatments
  Any thiopurine (yes/no) 2/0 13/18 6/18
  Anti-TNF-α antibody (yes/no) 2/0 15/16 14/12
Stricture site
  Single (%) 4 17 13
  Multiple (%) 2 14 13
    2 1   5   6
    3 1   7   4
    ≥4 0   2   3
Values are presented as mean±SD. 
SBE, single-balloon enteroscopy; EBD, endoscopic balloon dilatation; A1, ≤16 years; A2, 17–40 years; A3, >40 years; B1, non-stricturing, non-
penetrating; B2, stricturing; B3, penetrating; L1, ileal; L3, ileocolonic.
by using these prototype SBEs in patients with stricturing CD. 
The prototype SBEs did not contribute to the cumulative 
surgery-free survival rate (data not shown). Depth of insertion 
was increased with the prototype SBEs compared with the 
conventional SBE, but this difference did not directly improve 
the approach to stenosis located deep in the small intestine. In 
fact, the prototype SBEs did not increase the number of EBDs 
compared with the conventional SBE (2.1 ± 1.8 vs. 1.9 ± 1.4) 
(Fig. 3I). However, there appeared to be some cases where ste-
nosis could be approached using only a prototype SBE, so fur-
ther accumulation of cases is necessary in the future. 
There are some limitations to this study. First, this is a non-
randomized retrospective study. Therefore, the procedure 
time during insertion in the small intestine was not recorded. 
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Fig. 3. Insertability and scope used. Patients who underwent single-balloon enteroscopy (SBE) at least twice during the observation peri-
od were extracted and divided into 3 groups according to the scope used: (A, D, G) conventional SBE only; (B, E, H) prototype SBE only; 
and (C, F, I) both conventional and prototype SBEs. For comparison of deep insertability into the small intestine, the 2 most recent proce-
dures were compared in the conventional SBE only group and the prototype SBE only group. The most recent switching opportunity was 
compared in the group that underwent both conventional and prototype SBE. For each group, depth of insertion (A-C), procedure time 
(D-F), and number of endoscopic balloon dilatations (G-I) were compared using Wilcoxon’s signed-rank test. 
Fig. 4. Representative case. X-
ray images at the time of endo-
scopic balloon dilatation (EBD) 
at different time points in the 
same patient. Depth of inser-
tion and the number of EBDs 
were increased when using sin-
gle-balloon enteroscopy (SBE) 
with a passive bending mecha-
nism and high force transmis-
sion insertion tube. (A) Conven-
tional SBE: depth of insertion 
(70 cm) and number of EBDs 
(n=2). (B) Prototype SBE: depth 
of insertion (120 cm) and num-
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Because the procedure time includes the time of insertion in 
the large intestine, duration of EBD, and observation period, it 
was not possible for us to analyze the insertion time in the 
small intestine. Second, depth of insertion was measured us-
ing the method described by May et al.,21 but this method may 
be less accurate than the method using crystal violet reported 
by Takenaka et al.25 Third, the timing of the procedures com-
pared to analyze the insertability was different although these 
procedures were performed in the same patient. Therefore, 
the condition of the patient may have changed. Generally, the 
pathology of CD is progressive, so insertion of the enteroscope 
becomes increasingly difficult as intestinal deformity pro-
gresses. It should be noted that the insertability improved 
even though most of the procedures with a prototype SBE 
were performed later than those with the conventional SBE. 
In conclusion, the prototype SBEs with a passive bending 
mechanism and high force transmission insertion tube did 
not improve long-term EBD prognosis, but they did improve 
the depth of insertion compared with a conventional SBE. In 
addition, elevated CDAI was identified as a factor contributing 
to intestinal resection even in a cohort limited to CD patients 
with strictures in the small intestine. 
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Supplementary Table 1. Enteroscope Specifications
Specification 
Prototype SBE Conventional SBE
SIF-Y0013 SIF-Y0002 SIF-Y0007 SIF-Q260
Optical system
  Field of view (°) 140 140 Wide: 140, tele: 60 140
  Direction of view Forward viewing Forward viewing Forward viewing Forward viewing
  Depth of field (mm) 3–100 3–100 Wide: 7–100, tele: 2–3.5 5–100
  Magnification - - ×80 -
Distal end
  Outer diameter (mm) 9.2 9.2 9.9 9.2
Insertion tube
  Outer diameter (mm) 9.2 9.2 9.2 9.2
  High force transmission Yes Yes Yes No
Bending section
  Angulation range (°, U/D/R/L) 180/180/160/160 180/180/160/160  180/180/160/160   180/180/160/160
  Passive bending Yes Yes Yes No
Working length (mm) 2,000 2,000 2,000 2,000
Total length (mm) 2,345 2,345 2,345 2,345
Instrumental channel
  Inner diameter (mm) 3.2 2.8 2.8 2.8
Overtube ST-SB1 ST-SB1 ST-SB1 ST-SB1
SBE, single-balloon enteroscopy; U, up; D, down; R, right; L, left.
See “Prototype single-balloon enteroscopy with passive bending and high force transmission improves depth of in-
sertion in the small intestine” on page 229-237.
